Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

SCSHP Annual Meeting 2023 (North Charleston, SC)


To view the ACPE Flyer: Click here
 

Advanced Registration is now closed. You may register onsite at the SCSHP meeting registration desk located outside the Compass Ballroom at the North Charleston Marriott.

Registration Hours:

  • Thursday, March 2 (7:00 AM - 6:00 PM)
  • Friday, March 3 (7:30 AM - 3:30 PM)
 
Location: 
 North Charleston Marriott
4770 Goer Dr
North Charleston, SC 29406
 
For all continuing education session details, including speakers and learning objectives, please expand the individual sessions below! 
 

Date: Mar 2, 2023 08:00 AM - Mar 3, 2023 03:30 PM

CE Hours

12.00

CE Units

1.200

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

SCSHP

Requirements for CE Credit

In order to claim credit and have CE credit submitted to the CPE Monitor, participants must complete the following steps within 60 days of the event.  Completion of these steps within 30 days of the event will allow for any issues in transmission to NABP to be rectified by our office. The CPE Monitor will not accept credit that is submitted greater than 60 days after the event per NABP policy.
  1. Check in upon arrival at the meeting
  2. Complete the online program evaluations
  3. Provide the correct month and day of birth and NABP e-Profile ID.  Registration with a proper disclosure of your NABP E-Profile ID is a requirement for receiving Continuing Pharmacy Education.  To register with or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.  

 

 

 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Summarize trends in hospital pharmacy practice, including the adoption of best practices and Practice Advancement Initiative (PAI) 2030 recommendations
  2. Explain results of the ASHP National Survey of Pharmacy Practice related to current challenges in health-system pharmacy practice

Speaker(s)/Author(s)

Paul W. Bush, PharmD, MBA, BCPS, FASHP
Vice President for Global Resource Development and Consulting, American Society of Health-System Pharmacists (ASHP)

Activity Number

0062-9999-23-035-L04-P/T
Date: 03/02/23
Time: 08:15 AM - 09:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Review the current CDC immunization schedules
  2. Identify recently updated ACIP recommendations for routine vaccinations in adult patients
  3. Discuss hepatitis B, influenza, pneumococcal, zoster, and COVID-19 vaccine schedules
  4. Summarize recommendations regarding MMR, meningococcal, and varicella vaccines

Speaker(s)/Author(s)

Kayla Antosz, PharmD
Lead Antimicrobial Stewardship Pharmacist, ASC-SC; Clinical Instructor, University of South Carolina College of Pharmacy

Reagan Barfield, PharmD, BCPS
Clinical Assistant Professor, USC College of Pharmacy; Ambulatory Clinical Pharmacist, Prisma Health Family Medicine; PGY1 Residency Program Coordinator, Tandem Health - USC

Activity Number

0062-9999-23-043-L06-P/T
Date: 03/02/23
Time: 09:15 AM - 10:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Select an appropriate strategy for perioperative anticoagulant management
  2. Discuss recent shifts in the evidence-based management of anticoagulation after ischemic stroke
  3. Examine potential new anticoagulant therapies under investigation
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Review appropriate treatments for perioperative anticoagulant management
  2. Identify factors that impact the timing of anticoagulation after ischemic stroke
  3. Recognize potential new anticoagulant therapies under investigation

Speaker(s)/Author(s)

Joe Kramer, PharmD, BCPS, BCCCP
Clinical Pharmacy Manager, Trident Medical Center

Activity Number

0062-9999-23-044-L01-P/T
Date: 03/02/23
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Compare and contrast the classifications and stages of heart failure (HF)
  2. Apply therapeutic principles from the new 2022 AHA/ACC/HFSA heart failure guidelines, including initiation and titration of guideline-directed medical therapies (GDMT), to patient-specific scenarios
  3. Describe when and how additional medical therapies (beyond the core four GDMT) should be integrated into the management of HF with reduced ejection fraction (HFrEF)
  4. Explain practical strategies to mitigate potential barriers to GDMT initiation
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Compare and contrast the classifications and stages of heart failure (HF)
  2. Identify treatment options from the new 2022 AHA/ACC/HFSA HF guidelines for the different HF classifications
  3. Recognize potential barriers to guideline-directed medical therapy (GDMT) initiation

Speaker(s)/Author(s)

Jason S. Haney, PharmD, BCPS, BCCCP
Associate Professor, Medical University of South Carolina College of Pharmacy; Clinical Pharmacy Specialist, MUSC Health Pharmacotherapy Clinics

Activity Number

0062-9999-23-045-L01-P/T
Date: 03/02/23
Time: 11:30 AM - 12:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Activity Number

0062-9999-23-046-L01-P/T
Date: 03/02/23
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Evaluate the differences in lipid-lowering pharmacotherapy practices in Type 2 diabetes mellitus between rural and urban fairly qualified health center practice sites
  2. Evaluate the use of sodium zirconium cyclosilicate in critically ill patients
  3. Discuss COVID-19 vaccine enthusiasm and hesitancy amongst rural South Carolina populations

Activity Number

0062-9999-23-047-L01-P/T
Date: 03/02/23
Time: 03:00 PM - 04:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe the types of services most commonly offered by health system based Centralized Pharmacy Services
  2. Describe the advantages of placing a centralized pharmacy within a multipurpose shared services facility versus operating a standalone pharmacy
  3. List two potential criticisms of operating a centralized pharmacy

Speaker(s)/Author(s)

Ken Jozefczyk, MS, RPh, FASHP, BCSCP
Director Centralized Pharmacy Services, BayCare Health System

Activity Number

0062-9999-23-048-L04-P
Date: 03/02/23
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Describe the landscape of hyperlipidemia within South Carolina and its subsequent implications
  2. Identify the key differences between non-statin therapies and their place in therapy
  3. Formulate patient-specific questions to gain the most important information for building an appropriate treatment plan
  4. Apply the updated hyperlipidemia guidelines and treatment options to patient cases
At the completion of this activity, the pharmacy technician will be able to:
  1. Describe the landscape of hyperlipidemia within South Carolina
  2. Identify the key differences between non-statin therapies
  3. Apply the updated hyperlipidemia guidelines and treatment options to patient cases

Speaker(s)/Author(s)

Carrington Royals, PharmD
Clinical Pharmacist, Tandem Health

Activity Number

0062-9999-23-049-L01-P/T
Date: 03/03/23
Time: 08:15 AM - 09:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Evaluate treatment options for weight management, specifically weight loss
  2. Identify the risks and benefits associated with anti-obesity medications
  3. Summarize potential barriers to anti-obesity medications

Speaker(s)/Author(s)

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
Clinical Professor and Director of Pharmacy Education, University of South Carolina College of Pharmacy

Activity Number

0062-9999-23-050-L01-P/T
Date: 03/03/23
Time: 09:15 AM - 10:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Recognize the prevalence of medication diversion in the hospital setting
  2. Describe components of a medication diversion prevention and detection program
  3. Identify methods to detect medication diversion
  4. Discuss reporting requirements following suspected or confirmed medication diversion

Speaker(s)/Author(s)

Sarah Bush Mattmuller, PharmD, BCPS
Assistant Director of Pharmacy, Trident Medical Center

Activity Number

0062-9999-23-051-L04-P/T
Date: 03/03/23
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Identify and explain the newest legislation impacting pharmacy practice
  2. Review older regulations and requirements that may cause board citations or confusion in your pharmacy

Speaker(s)/Author(s)

Nancy A. Taylor, RPh, CDCES
Assistant Professor, Presbyterian College School of Pharmacy

Activity Number

0062-9999-23-052-L03- P/T
Date: 03/03/23
Time: 11:30 AM - 12:00 PM

CE Hours

0.50
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Review the etiology and current guideline recommendations for the management of urinary tract infections
  2. Discuss the primary literature surrounding duration of therapy for urinary tract infections in the male population
  3. Discuss the primary literature surrounding the safety and efficacy of urinary tract infection prophylaxis in high-risk populations

Speaker(s)/Author(s)

Michael K. Shaw, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland

Activity Number

0062-9999-23-053-L01-P/T
Date: 03/03/23
Time: 12:00 PM - 12:30 PM

CE Hours

0.50
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Identify antifungal agents in the pipeline and their potential role in therapy
  2. Discuss potential treatment strategies for persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
  3. Utilize temperature excursion resources to optimize temperature excursion management
  4. Review the role of terlipressin in the management of hepatorenal syndrome

Speaker(s)/Author(s)

Abbie L. Blunier, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland

Cassidy H. Kemp, PharmD
PGY2 Health System Pharmacy Administration and Leadership (HSPAL) Resident, Prisma Health Richland Hospital

Jake Crocker, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland

Justin White, PharmD
PGY1 Pharmacy Resident, Bon Secours St. Francis Downtown

Activity Number

0062-9999-23-054-L01-P/T
Date: 03/03/23
Time: 02:30 PM - 03:30 PM

CE Hours

1.00